{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:09:57Z","timestamp":1772770197963,"version":"3.50.1"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T00:00:00Z","timestamp":1618531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004605","name":"Zhengzhou University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004605","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The use of frozen embryo transfer (FET) cycles has dramatically risen. The optimal endometrial preparation method for women undergoing FET is of utmost importance to provide the optimal chances of pregnancy. For patients with abnormal ovulation in particular, there have been few studies on FET protocols; notably, most of these studies focus only on the clinical pregnancy rate or live birth rate (LBR) and pay little attention to the regimen\u2019s safety for offspring.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>It was a retrospective cohort study. First FET cycle with a single blastocyst from whole embryo frozen IVF\/ICSI at the Reproductive Center of Third Affiliated Hospital of Zhengzhou University between January 2016 and January 2020. The LBR was the primary outcome of interest. The secondary outcome measures were miscarriage rate and offspring safety, including preterm birth, low birthweight (LBW), small-for-gestational age (SGA), macrosomia and large-for-gestational age (LGA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 2782 FET cycles met the eligibility criteria for analysis. Additionally, there were 1178 singleton births from FET cycles. The clinical pregnancy rate was 58.4% in the L-FET group and 54.5% in the HRT group, with no statistical significance (P=.116). The miscarriage rate was higher in the HRT group than in the L-FET group (21.7% vs. 14.3%, P=.005). The LBR was significantly higher in the L-FET group than in the HRT group (49.6% vs. 41.7%, P=.001). Neonatal outcomes were similar between the two groups. After adjustments for confounding factors, the LBR was higher in the L-FET group (aOR 1.30, 95% CI 1.06-1.58). The rate of miscarriage was lower in the L-FET group (aOR 0.63, 95% CI 0.44-0.90).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>For patients with abnormal ovulation, the L-FET regimen has a higher LBR and lower miscarriage rate than HRT. The neonatal outcomes were similar between the two groups.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2021.664072","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T19:01:43Z","timestamp":1618599703000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Comparison of Pregnancy and Neonatal Outcomes of Single Frozen Blastocyst Transfer Between Letrozole-Induction and HRT Cycles in Patients With Abnormal Ovulation"],"prefix":"10.3389","volume":"12","author":[{"given":"Junwei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yichun","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingze","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.06.028","article-title":"A fresh(er) perspective on frozen embryo transfers","volume":"106","author":"Pereira","year":"2016","journal-title":"Fertil Steril"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dex264","article-title":"Assisted reproductive technology in Europe, 2013: results generated from European registers by ESHRE","volume":"32","author":"Gliozheni","year":"2017","journal-title":"Hum Reproduct"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmw038","article-title":"Oocyte, embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance","volume":"23","author":"Rienzi","year":"2017","journal-title":"Hum Reprod Update"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.02.135","article-title":"Programming the endometrium for deferred transfer of cryopreserved embryos: hormone replacement versus modified natural cycles","volume":"109","author":"Groenewoud","year":"2018","journal-title":"Fertil Steril"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dey242","article-title":"ART in Europe, 2014: results generated from European registries by ESHRE: The European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE)","volume":"33","author":"De Geyter","year":"2018","journal-title":"Hum Reproduct"},{"key":"B6","doi-asserted-by":"publisher","first-page":"CD003414","DOI":"10.1002\/14651858.CD003414.pub3","article-title":"Cycle regimens for frozen-thawed embryo transfer","volume":"7","author":"Ghobara","year":"2017","journal-title":"Cochrane Database System Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"CD006359","DOI":"10.1002\/14651858.CD006359.pub3","article-title":"Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes","volume":"10","author":"Glujovsky","year":"2020","journal-title":"Cochrane Database System Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dex285","article-title":"Frozen embryo transfer: a review on the optimal endometrial preparation and timing","volume":"32","author":"Mackens","year":"2017","journal-title":"Hum Reproduct"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2019.04.014","article-title":"Letrozole use during frozen embryo transfer cycles in women with polycystic ovary syndrome","volume":"112","author":"Zhang","year":"2019","journal-title":"Fertil Steril"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12280","article-title":"Letrozole stimulation in endometrial preparation for cryopreserved-thawed embryo transfer in women with polycystic ovarian syndrome: a pilot study","volume":"80","author":"Hu","year":"2014","journal-title":"Clin Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.18502\/ijrm.v17i12.5793","article-title":"Frozen embryo transfer: Endometrial preparation by letrozole versus hormone replacement cycle: A randomized clinical trial","volume":"17","author":"Samsami","year":"2019","journal-title":"Int J Reprod BioMed"},{"key":"B12","doi-asserted-by":"publisher","first-page":"Cd010287","DOI":"10.1002\/14651858.CD010287.pub2","article-title":"Aromatase inhibitors for subfertile women with polycystic ovary syndrome","volume":"2","author":"Franik","year":"2014","journal-title":"Cochrane Database System Rev"},{"key":"B13","doi-asserted-by":"publisher","first-page":"Cd010287","DOI":"10.1002\/14651858.CD010287.pub3","article-title":"Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome","volume":"5","author":"Franik","year":"2018","journal-title":"Cochrane Database System Rev"},{"key":"B14","doi-asserted-by":"publisher","first-page":"CD002249","DOI":"10.1002\/14651858.CD002249.pub5","article-title":"Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome","volume":"12","author":"Brown","year":"2016","journal-title":"Cochrane Database System Rev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/01.ogx.0000248776.88202.f7","article-title":"Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate","volume":"85","author":"Tulandi","year":"2006","journal-title":"Fertil Steril"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.02.092","article-title":"Drugs in infertility and fetal safety","volume":"89","author":"Elizur","year":"2008","journal-title":"Fertil Steril"},{"key":"B17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12958-020-00675-z","article-title":"The effect of letrozole versus artificial hormonal endometrial preparation on pregnancy outcome after frozen-thawed embryos transfer cycles: a randomized clinical trial","volume":"18","author":"Hosseini-Najarkolaei","year":"2020","journal-title":"Reprod Biol Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dex066","article-title":"Pregnancy and neonatal outcomes following letrozole use in frozen-thawed single embryo transfer cycles","volume":"32","author":"Tatsumi","year":"2017","journal-title":"Hum Reproduct"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e104779","DOI":"10.1371\/journal.pone.0104779","article-title":"Birth weight reference percentiles for Chinese","volume":"9","author":"Dai","year":"2014","journal-title":"PloS One"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12280","article-title":"Letrozole stimulation in endometrial preparation for cryopreserved-thawed embryo transfer in women with polycystic ovarian syndrome: a pilot study","volume":"80","author":"Hu","year":"2014","journal-title":"Clin Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-013-3044-0","article-title":"Letrozole ovulation induction: an effective option in endometrial preparation for frozen-thawed embryo transfer","volume":"289","author":"Li","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12958-017-0255-4","article-title":"Comparative neonatal outcomes in singleton births from blastocyst transfers or cleavage-stage embryo transfers: a systematic review and meta-analysis","volume":"15","author":"Wang","year":"2017","journal-title":"Reprod Biol Endocrinol RB&E"},{"key":"B23","doi-asserted-by":"publisher","first-page":"Cd002118","DOI":"10.1002\/14651858.CD002118.pub5","article-title":"Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology","volume":"6","author":"Glujovsky","year":"2016","journal-title":"Cochrane Database System Rev"},{"key":"B24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3390\/medicina55060293","article-title":"Cleavage Stage versus Blastocyst Stage Embryo Transfer in Oocyte Donation Cycles","volume":"55","author":"Kontopoulos","year":"2019","journal-title":"Medicina (Kaunas Lithuania)"},{"key":"B25","article-title":"Relationship of Number of Embryos Transferred with Perinatal Outcome of Singleton Pregnancy","volume":"18","author":"Bhandari","year":"2017","journal-title":"J Reprod Infertil"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.humrep.a138250","article-title":"The influence of the number of embryos transferred in 1060 in-vitro fertilization pregnancies on miscarriage rates and pregnancy outcome","volume":"8","author":"Balen","year":"1993","journal-title":"Hum Reproduct"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/GRF.0b013e3182353d0f","article-title":"Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome","volume":"54","author":"Casper","year":"2011","journal-title":"Clin Obstet Gynecol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2012.09.042","article-title":"The use of aromatase inhibitors in in\u00a0vitro fertilization","volume":"98","author":"Garcia-Velasco","year":"2012","journal-title":"Fertil Steril"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3109\/19396368.2013.862316","article-title":"Endometrial receptivity markers in infertile women stimulated with letrozole compared with clomiphene citrate and natural cycles","volume":"60","author":"Ganesh","year":"2014","journal-title":"Syst Biol Reprod Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.664072\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T19:01:46Z","timestamp":1618599706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.664072\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,16]]},"references-count":29,"alternative-id":["10.3389\/fendo.2021.664072"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.664072","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,16]]},"article-number":"664072"}}